000			02079 a2200637 4500
005			20250518011459.0
264		0	_c20190211
008			201902s 0 0 chi d
022			_a1007-3418
024	7		_a10.3760/cma.j.issn.1007-3418.2018.10.005 _2doi
040			_aNLM _beng _cNLM
100	1		_aHu, P
245	0	0	_a[HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study]. _h[electronic resource]
260			_bZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _cOct 2018
300			_a756-764 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aDNA, Viral
650	0	4	_aHepatitis B Surface Antigens _ximmunology
650	0	4	_aHepatitis B e Antigens _ximmunology
650	0	4	_aHepatitis B, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aRecombinant Proteins
650	0	4	_aTreatment Outcome
700	1		_aShang, J
700	1		_aZhang, W H
700	1		_aGong, G Z
700	1		_aLi, Y G
700	1		_aChen, X Y
700	1		_aJiang, J N
700	1		_aXie, Q
700	1		_aDou, X G
700	1		_aSun, Y T
700	1		_aLi, Y F
700	1		_aLiu, Y X
700	1		_aLiu, G Z
700	1		_aMa, D W
700	1		_aChi, X L
700	1		_aTang, H
700	1		_aLi, X O
700	1		_aXie, Y
700	1		_aChen, X P
700	1		_aJiang, J J
700	1		_aZha, P
700	1		_aHou, J L
700	1		_aGao, Z L
700	1		_aFan, H M
700	1		_aDing, J G
700	1		_aZhang, D Z
700	1		_aRen, H
773	0		_tZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology _gvol. 26 _gno. 10 _gp. 756-764
856	4	0	_uhttps://doi.org/10.3760/cma.j.issn.1007-3418.2018.10.005 _zAvailable from publisher's website
999			_c29096099 _d29096099